5Winawer SJ, Fletcher RH, Miller L, Godlee F,Stolar MH, Mulrow CD, Woolf SH, Glick SN,Ganiats TG, Bond JH, Rosen L, Zapka JG, OlsenSJ, Giardiello FM, Sisk JE, Van Antwerp R,Brown-Davis C, Marciniak DA, Mayer RJ. Colorectal cancer screening: clinical guidelines andrationale. Gastroenterology, 1997, 112: 594～642.
6Noshirwani KC, van Stolk RU, Rybicki LA, BeckGJ. Adenoma size and number are predictive ofadenoma recurrence: implications for surveillancecolonoscopy. Gastrointest Endosc, 2000, 51 (4 Pt 1):433 ～437.
7Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable tothe endoscopic estimate. Gastrointest Endosc, 1997,46: 492～496.
8van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence andcharacteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology, 1998, 115:13～18.
9Zauber AG, Winawer SJ, Bond JH, Wayne JD,Schaqiro M, Stewart ET. Can surveillance intervals be lengthened following colonoscopic polypectomy? Gastroenterology, 1998, 112: A50.
10van Stolk RU, Beach M, Baron JA, GreenbergER. For the Polyp Prevention Group. Incidence ofcolorectal cancer during colonoscopic surveillance in a four year polyp prevention trial. Gastroenterology, 1998, 114: A697.
1Shike M, Winawer S J, Greenwald PH, et al. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer [ J ]. Bull World Health Organ, 1990, 68 (3) : 377-385.
2Yang L, Parkin DM, Li L, et al. Time trends in cancer mortality in China: 1987-1999 [ J]. Int J Cancer, 2003, 106 (5): 771-783.
3Winawer S J, Zanber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup [ J ]. N Engl J Med, 1993, 329 (27) : 1977-1981.
4Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human coloreetal cancer cells [ J]. Biochem Biophys Res Commun, 2010, 400 (2) : 236-240.
6Moriyama T, Ohuchida K, Mizumoton K, et al. MieroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistanee[ J]. Mol Cancer Ther, 2009, 8 (5) : 1067-1074.
7Lieberman DA. Targeted colon cancer screening: a concept whose time almost come [ J]. Am J Gastroenterol, 1992, 87 (9): 1085-1093.
8Tamura S, Nakajo K, Yokoyama Y, et al. Evaluation of endoscopic mucosal resection for laterally spreading rectal tumors[J]. Endoscopy, 2004, 36 (4): 306-312.
9Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population [ J ]. BMC Gastroenterol, 2010, 10: 51.
10Sun Z J, Huang YH, Wu JS, et al. The association of serum lipids with the histological pattern of rectosigmoid adenoma in Taiwan Residents aduhs [ J ]. BMC Gastroenterol, 2011, 11 : 54.
